secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2026-08-06T20:05:37+00:00
Accession:  0001193125-26-337962
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q4 revenue up 9% to $1.5B; non-GAAP EPS $2.95 (+16%); dividend raised 10%
--------------------------------------------------------------------------------

- Q4 revenue $1.464B (+9% YoY); GAAP EPS $2.64 (+2%); non-GAAP EPS $2.95 (+16%).
- FY2026 revenue $5.653B (+10%); GAAP EPS $10.43; non-GAAP EPS $11.17 (+17%).
- FY2026 free cash flow $1.6B; returned $1.0B to shareholders; FY2027 capital return guided >$1.85B.
- Dividend increased 10% to $0.66/quarter; record date Aug 20, payable Sep 24.
- Agreement to sell MatrixCare (close Q1 FY2027); completed acquisition of Noctrix Health.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312526337962/0001193125-26-337962-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312526337962/d158732d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-337962

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer